Patients' and Consumers' Working Party
Table of contents
The Patients' and Consumers' Working Party (PCWP) provides a platform for exchange of information and discussion of issues of common interest between EMA and patients and consumers.
The PCWP, established in 2006, has enabled the Agency to build upon its existing interactions with patients and consumers. It provides recommendations to EMA and its human scientific committees on all matters of interest in relation to medicines.
The following documents provide information on the PCWP's responsibilities and composition:
-
List item
Mandate, objectives and composition of the Patients and Consumers Working Party (PCWP) (PDF/94.18 KB)
Adopted
First published: 07/09/2006
Last updated: 13/05/2019
EMA/563123/2018 Rev. 4 -
List item
Rules of procedure for the Patients and Consumers Working Party (PCWP) and the Healthcare Professionals Working Party (HCPWP) (PDF/169.36 KB)
First published: 20/02/2019
Last updated: 13/05/2019
EMA/109591/2018 Rev.1 -
List item
2022-2025 Work plan for the Patients’ and Consumers’ Working Party (PCWP) and the Healthcare Professionals’ Working Party (HCPWP) (PDF/346.9 KB)
First published: 25/09/2019
Last updated: 26/01/2023
EMA/22769/2022
For information on upcoming and past meetings of the PCWP, including meeting materials, see:
The PCWP consists of:
- a core group of representatives from the eligible patients' and consumers' organisations;
- representatives from EMA's scientific committees;
- observers from:
- the EMA Management Board;
- the European Commission;
- the Healthcare Professionals Working Party;
- the Coordination Group for Mutual Recognition and Decentralised Procedures – Human.
The members' declarations of interests are available in the European experts list.
Co-chairs
Affiliation | Co-chairs |
---|---|
EMA | Juan Garcia Burgos |
European Liver Patients' Association (ELPA) | Marko Korenjak |
Organisation representative members
Members representing EMA's scientific committees
Scientific Committee | Representative(s) |
---|---|
Committee for Advanced Therapies | Mencia de Lemus Belmonte Kerstin Elisabeth Sollerbrant Melefors |
Committee for Medicinal Products for Human Use | Concepción Prieto Yerro Fàtima Ventura |
Committee for Orphan Medicinal Products | Tim Leest |
Committee on Herbal Medicinal Products | An Le Olga Maria Palomino |
Paediatric Committee | Dimitrios Athanasiou Johannes Taminiau |
Pharmacovigilance Risk Assessment Committee | Declan Noone Marko Korenjak |
Observers
Observer affiliation | Representative(s) |
---|---|
EMA Management Board | Marco Greco Virginie Hivert |
Healthcare Professionals Working Party | Anita Simonds Rui Castro |
European Commission (DG SANTE) | Rotating membership |
Coordination Group for Mutual Recognition and Decentralised Procedures - Human (CMDh) | Nina Malvik |